Insider Trading & Ownership of Flagship Pioneering Fund VII General Partner LLC

Location: Cambridge, MA
Summary: The estimated value of insider holdings of Flagship Pioneering Fund VII General Partner LLC is at least $23,019,558 dollars as of 24 May 2024. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Omega Therapeutics, Inc. and owns shares of Omega Therapeutics, Inc. stock worth about $10.63M. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Seres Therapeutics, Inc. and owns shares of Seres Therapeutics, Inc. (MCRB) stock worth about $7.86M. Flagship Pioneering Fund VII General Partner LLC is the 10%+ Owner of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. (EVLO) stock worth about $4.52M.
Signature: Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, PhD., Chief Executive Officer
All Insider Reports: All Insider Reports

Notify me when Flagship Pioneering Fund VII General Partner LLC files a new Insider Trading report.

Ownership of Flagship Pioneering Fund VII General Partner LLC

Symbol	Company	Relationship	Holdings Value	Report Period
OMGA	Omega Therapeutics, Inc.	10%+ Owner	$10,634,592	27 Feb 2023
MCRB	Seres Therapeutics, Inc.	10%+ Owner	$7,864,418	05 Jul 2022
EVLO	Evelo Biosciences, Inc.	10%+ Owner	$4,520,548	27 May 2022
FHTX	Foghorn Therapeutics Inc.	10%+ Owner		22 May 2024
SANA	Sana Biotechnology, Inc.	10%+ Owner		12 Feb 2024